Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

por Khanna, Nina, Weisser, Maja, Hedstueck, Anemone, Sutter, Sarah Tschudin, Roesch, Sandra, Battegay, Manuel, Infanti, Laura, Holbro, Andreas, Busch, Michael Paul, Simmons, Graham, Felgner, Philip, Stone, Mars, von Goetz, Melissa, de Assis, Rafael, Khan, Saahir, Tsai, Jason, Robinson, Peter, Seftel, David, Bagri, Anil, Corash, Laurence, Buser, Andreas S.
Publicado 2020

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment

por Bagri, Anil, de Assis, Rafael R., Tsai, Cheng‐Ting, Simmons, Graham, Mei, Zhen W., Von Goetz, Melissa, Gatmaitan, Michelle, Stone, Mars, Di Germanio, Clara, Martinelli, Rachel, Darst, Orsolya, Rioveros, Jowin, Robinson, Peter V., Ward, Dawn, Ziman, Alyssa, Seftel, David, Khan, Saahir, Busch, Michael P., Felgner, Philip L., Corash, Laurence M.
Publicado 2022